Distal technologies and type 1 diabetes management.

Related Articles

Distal technologies and type 1 diabetes management.

Lancet Diabetes Endocrinol. 2018 02;6(2):143-156

Authors: Duke DC, Barry S, Wagner DV, Speight J, Choudhary P, Harris MA

Abstract
Type 1 diabetes requires intensive self-management to avoid acute and long-term health complications. In the past two decades, substantial advances in technology have enabled more effective and convenient self-management of type 1 diabetes. Although proximal technologies (eg, insulin pumps, continuous glucose monitors, closed-loop and artificial pancreas systems) have been the subject of frequent systematic and narrative reviews, distal technologies have received scant attention. Distal technologies refer to electronic systems designed to provide a service remotely and include heterogeneous systems such as telehealth, mobile health applications, game-based support, social platforms, and patient portals. In this Review, we summarise the empirical literature to provide current information about the effectiveness of available distal technologies to improve type 1 diabetes management. We also discuss privacy, ethics, and regulatory considerations, issues of global adoption, knowledge gaps in distal technology, and recommendations for future directions.

PMID: 28867311 [PubMed - indexed for MEDLINE]